Preview Mode Links will not work in preview mode
  1. All Episodes
  2. For Oncology Nurses: Antibody-Drug Conjugates for Breast Cancer and Lung Cancer — Proceedings from the 2025 Annual ONS Congress

For Oncology Nurses: Antibody-Drug Conjugates for Breast Cancer and Lung Cancer — Proceedings from the 2025 Annual ONS Congress

Apr 26, 2025

Featuring perspectives from Ms Marianne J Davies, Dr Edward B Garon, Ms Marissa Marti-Smith and Dr Tiffany A Traina, including the following topics:

  • Introduction (0:00)
  • Overview of Antibody-Drug Conjugates (ADCs) (4:40)
  • Trastuzumab Deruxtecan (T-DXd) in Patients with HER2-Positive Metastatic Breast Cancer (mBC) with and without Brain Metastases (12:40)
  • Role of ADCs for Patients with ER-Positive mBC (35:09)
  • T-DXd in Patients with Metastatic Non-Small Cell Lung Cancer (NSCLC) with HER2 Alterations (52:20)
  • Emerging Role of ADCs for Patients with Progressive EGFR-Mutant NSCLC (1:12:20)

NCPD information and select publications